4051 - 4075 of 6082 Results
Title
Year
- Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s disease2019OPENTitle: Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 2Start Page: e0211699End Page: e0211699Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0211699Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0211699&type=printableCitation Count: 9
- Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease2019OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: http://manuscript.elsevier.com/S135380201930032X/pdf/S135380201930032X.pdfCitation Count: 23
-
OPENTitle: Neural correlates of distinct cognitive phenotypes in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 399Issue #:Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.02.013Best OA location URL: https://europepmc.org/articles/pmc6436969?pdf=renderCitation Count: 10
- Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD2019OPENTitle: Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 879End Page: 899Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-019-01962-9Best OA location URL: https://europepmc.org/articles/pmc6533145?pdf=renderCitation Count: 102
-
OPENTitle: An estimate of the total number of true human miRNAsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 47Issue #: 7Start Page: 3353End Page: 3364Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkz097Best OA location URL: https://academic.oup.com/nar/article-pdf/47/7/3353/28467549/gkz097.pdfCitation Count: 494
-
OPENTitle: Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 538End Page: 549Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25430Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25430Citation Count: 151
- l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease2019OPENTitle: l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 31
- Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph2019OPENTitle: Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorphJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0469-0Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-019-0469-0Citation Count: 127
- The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A2019OPENTitle: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 13Start Page: 4738End Page: 4758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra118.005008Best OA location URL: https://europepmc.org/articles/pmc6442034?pdf=renderCitation Count: 69
- Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansion2019OPENTitle: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansionJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 699Issue #:Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056Best OA location URL: https://europepmc.org/articles/pmc6443492?pdf=renderCitation Count: 9
- Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease2019OPENTitle: Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 12Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12619Best OA location URL: https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12619Citation Count: 18
-
OPENTitle: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0470-7Best OA location URL: https://doi.org/10.1186/s13195-019-0470-7Citation Count: 140
- Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)2019OPENTitle: Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 201End Page: 209Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978879Citation Count: 19
- Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders2019OPENTitle: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian DisordersJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 3Start Page: 423End Page: 435Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669119Citation Count: 82
- Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's disease2019OPENTitle: Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.022Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/636639/2/1-s2.0-S1353802019300227-main.pdfCitation Count: 81
- Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder2019OPENTitle: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorderJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0073-1Best OA location URL: https://www.nature.com/articles/s41531-018-0073-1.pdfCitation Count: 29
-
OPENTitle: Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 115Issue #:Start Page: 99End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cortex.2019.01.016Best OA location URL: http://manuscript.elsevier.com/S0010945219300358/pdf/S0010945219300358.pdfCitation Count: 30
- Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study2019OPENTitle: Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort StudyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-37545-zBest OA location URL: https://www.nature.com/articles/s41598-018-37545-z.pdfCitation Count: 130
- Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patients2019OPENTitle: Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.021Best OA location URL: http://manuscript.elsevier.com/S1353802019300215/pdf/S1353802019300215.pdfCitation Count: 45
- The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease2019OPENTitle: The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 460End Page: 468Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27614Best OA location URL: https://europepmc.org/articles/pmc6467788?pdf=renderCitation Count: 75
-
OPENTitle: miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signalingJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1295-1Best OA location URL: https://www.nature.com/articles/s41419-018-1295-1.pdfCitation Count: 66
-
OPENTitle: Multimodal MRI evaluation of parkinsonian limbic pathologiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 194End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004Best OA location URL: https://europepmc.org/articles/pmc6461740?pdf=renderCitation Count: 14
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://europepmc.org/articles/pmc6467782?pdf=renderCitation Count: 21
- Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION2019OPENTitle: Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinIONJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.564Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.564Citation Count: 76
-
OPENTitle: Identifying the neural correlates of doorway freezing in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 7Start Page: 2055End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24506Best OA location URL: https://europepmc.org/articles/pmc6865388?pdf=renderCitation Count: 44